Latest common stock for PROC: $1M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
Procaps Group S.A posts a common stock of $1M as of September 2023. That compares with $1M in the prior-year period — up 0.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Procaps Group S.A's common stock was $1M. The latest reading is $1M — essentially flat versus a year earlier (period ending September 2023). Use the history and growth charts on this page for a longer lookback.
Common Stock is one piece of Procaps Group S.A's financial statement story. At $1M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for PROC's common stock usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Procaps Group S.A's other metric pages and overview cover the third.
Judging Procaps Group S.A against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in common stock easier to interpret. Start with $1M here, then scan peer and history charts to see if the gap is persistent.